Precision Medical Products (PMP) Partners with Synergy Biomedical as Contract Manufacturer for BioSphere Putty, a Next Generation Bioactive Bone Graft
COLLEGEVILLE, Pa.–(BUSINESS WIRE)–Synergy Biomedical, LLC (www.synergybiomedical.com) announced today that it has recently received FDA clearance and will be launching its first bone graft product, BioSphere™ Putty. Utilizing a specialized form of 45S5 bioactive glass with a unique sphere shape and a narrow size range, BioSphere™ Putty provides an optimized bone graft material that outperforms other bioactive products. The spherical shape of the BioSphere™ particles provides uniform and repeatable resorption and ion release. In addition, the 3-D packing of the spheres in a bone defect creates an optimal porosity that allows bone formation throughout the implant. Biosphere™ Putty is composed of bioactive glass spheres that are combined with a moldable phospholipid carrier. The Putty has the highest bioactive glass composition on the market, provides excellent handling, and is resistant to irrigation. This combination results in a high performance bone graft that provides faster and more robust bone formation.
“The use of spherical particles has allowed Synergy to identify an optimal form of bioactive glass that improves bone formation”
“The use of spherical particles has allowed Synergy to identify an optimal form of bioactive glass that improves bone formation,” stated Mark Borden, Ph.D., CEO and founder of Synergy Biomedical. “We are excited to introduce a next generation bone graft product to the orthopedic community that represents an advancement in bone grafting technology,” stated Dr. Borden.
About Synergy Biomedical, LLC
Founded in 2011, Synergy Biomedical is a privately-held medical device company focused on bringing innovative biomaterial based products to the orthopedic and spinal markets. The Company’s BioSphere™ Technology represents a unique approach to advancing bone graft technology, and improving bone healing and patient outcomes.